Access cutting-edge solid tumors treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Omaha at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
KB707-01 is a Phase 1/2, open-label, multicenter, dose escalation and expansion study. The study will evaluate the safety and tolerability of KB707 in adults with locally advanced or metastatic solid tumors who have progressed on standard of care therapy, cannot tolerate standard of care therapy, refused standard of care therapy, or for whom there is no standard of care therapy as well as the safety, tolerability, preliminary efficacy, and immunologic effect of KB707 administered in combination
Sponsor: Krystal Biotech, Inc.
Check if you qualify for this solid tumors clinical trial in Omaha, NE
If you're searching for solid tumors treatment options in Omaha, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.